MedTrace Logo

How Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes

NCT05672745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 256

Last updated 2023-01-05

No results posted yet for this study

Summary

The goal of this observational study is to understand the characteristics of Woebot users as they relate to clinical outcomes.

The objectives it aims to address are:

1. To assess Woebot usage patterns, satisfaction ratings, self-efficacy, stress, resilience, work productivity and activity impairment, alexthymia, and bond over time based on demographic, clinical baseline levels, and attitudinal characteristics
2. Among users who present with clinical levels of anxiety or depression, to assess the contribution of demographic characteristics, attitudinal characteristics, and patterns of engagement on clinical outcomes of interest over time
3. To collect and explore attitudinal characteristics of Woebot users regarding their experiences with mental health care and perceived value of digital tools for emotional support
4. Explore meaningful subgroups of Woebot users based on demographic and attitudinal characteristics, clinical outcomes, and patterns of engagement

Participants who meet study eligibility requirements will be:

* invited to engage with the Woebot Life program for 8 weeks
* complete survey assessments at day 3, week 4 (mid-intervention), and week 8 (end of intervention)

Conditions

  • To Understand the Characteristics of Digital Mental Health Intervention Users as They Relate to Mental Health Outcomes

Interventions

DEVICE

WB-LIFE

WB-LIFE is a mobile application program grounded in validated psychotherapies (including cognitive behavioral therapy, interpersonal, and dialectical behavioral therapy), that enlists the relational agent Woebot to guide users in managing their mood. The user experience is driven by artificial intelligence and centers around mood tracking, evidence-based tools, and goal-oriented, tailored conversations.

Sponsors & Collaborators

  • Woebot Health

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-11
Primary Completion
2022-07-23
Completion
2022-07-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05672745 on ClinicalTrials.gov